USD 0.65
(-8.1%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 148.99 Million | 145.25 Million | 117.32 Million | 71.27 Million |
Cost of Revenue | 111.99 Million | 112.71 Million | 90.92 Million | 56.92 Million |
Gross Profit | 37 Million | 32.53 Million | 26.39 Million | 14.35 Million |
Operating Expenses | 23.68 Million | 22.39 Million | 15.25 Million | 7.76 Million |
Selling, General and Administrative Expenses | 23.68 Million | 22.39 Million | 15.25 Million | 7.76 Million |
Research and Development Expenses | - | - | - | - |
Other Expenses | - | 351.34 Thousand | 15.05 Thousand | 776.52 Thousand |
Cost and Expenses | 135.67 Million | 135.11 Million | 106.17 Million | 64.68 Million |
Operating Income | 13.32 Million | 10.14 Million | 11.14 Million | 6.58 Million |
Interest Expense | 842.24 Thousand | 612.55 Thousand | 787.52 Thousand | 313.39 Thousand |
Income Tax Expense | 1.94 Million | 1.46 Million | 1.36 Million | 1.01 Million |
Earnings before Tax | 11.69 Million | 9.37 Million | 10.05 Million | 6.95 Million |
Net Income | 9.75 Million | 7.9 Million | 8.69 Million | 5.94 Million |
Earnings Per Share Basic | 0.24 | 0.18 | 0.21 | 0.14 |
Earnings Per Share Diluted | 0.24 | 0.18 | 0.21 | 0.14 |
Weighted Average Shares Outstanding | 39.45 Million | 37.73 Million | 37.73 Million | 42.35 Million |
Weighted Average Shares Outstanding (Diluted) | 39.45 Million | 37.73 Million | 37.73 Million | 42.35 Million |
Gross Margin | 0.25 | 0.22 | 0.22 | 0.20 |
EBIT Margin | 0.09 | 0.08 | 0.10 | 0.10 |
Profit Margin | 0.07 | 0.05 | 0.07 | 0.08 |
EBITDA | 13.41 Million | 10.4 Million | 11.26 Million | 6.69 Million |
Earnings Before Tax Margin | 0.09 | 0.07 | 0.09 | 0.09 |
Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Revenue | 33.66 Million | 148.99 Million | 33.66 Million | 40.83 Million | 40.83 Million | 145.25 Million |
Cost of Revenue | 24.99 Million | 111.99 Million | 24.99 Million | 30.99 Million | 30.99 Million | 112.71 Million |
Gross Profit | 8.66 Million | 37 Million | 8.66 Million | 9.83 Million | 9.83 Million | 32.53 Million |
Operating Expenses | 6.08 Million | 23.68 Million | 6.08 Million | 6.15 Million | 195.76 Thousand | 22.39 Million |
Selling, General and Administrative Expenses | 6.04 Million | - | 6.04 Million | 5.79 Million | 195.76 Thousand | - |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | 55.44 Thousand | - | - | - | 351.34 Thousand |
Cost and Expenses | 31.08 Million | 135.67 Million | 31.08 Million | 37.14 Million | 195.76 Thousand | 135.11 Million |
Operating Income | 2.62 Million | 13.32 Million | 2.62 Million | 4.03 Million | -195.76 Thousand | 10.14 Million |
Interest Expense | - | 842.24 Thousand | - | - | - | 612.55 Thousand |
Income Tax Expense | 459.1 Thousand | 1.94 Million | 459.1 Thousand | 511.31 Thousand | 511.31 Thousand | 1.46 Million |
Earnings before Tax | 2.5 Million | 11.69 Million | 2.5 Million | 3.33 Million | 561.56 Thousand | 9.37 Million |
Net Income | 2.15 Million | 9.75 Million | 2.15 Million | 2.72 Million | 561.56 Thousand | 7.9 Million |
Earnings Per Share Basic | 0.05 | - | 0.05 | 0.07 | 0.01 | - |
Earnings Per Share Diluted | 0.05 | - | 0.05 | 0.07 | 0.01 | - |
Weighted Average Shares Outstanding | 39.45 Million | 39.45 Million | 39.45 Million | 39.45 Million | 39.45 Million | 37.73 Million |
Weighted Average Shares Outstanding (Diluted) | 39.45 Million | 39.45 Million | 39.45 Million | 39.45 Million | 39.45 Million | 37.73 Million |
Gross Margin | 0.26 | 0.25 | 0.26 | 0.24 | 0.24 | 0.22 |
EBIT Margin | 0.08 | - | 0.08 | 0.10 | -0.00 | - |
Profit Margin | 0.06 | 0.07 | 0.06 | 0.07 | 0.01 | 0.05 |
EBITDA | 2.69 Million | - | 2.69 Million | 4.07 Million | -195.76 Thousand | - |
Earnings Before Tax Margin | 0.08 | 0.09 | 0.08 | 0.10 | -0.00 | 0.07 |
FNINF
NGD
600518
ARTEMISMED
AUMC
PEB-PG